Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients

NCT02338115 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02338115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients
Lead sponsor
University of Michigan Rogel Cancer Center
Phase
Observational
Overall status
Completed
Start date
May 31, 2014
Completion date
December 20, 2016
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer